News
The Top 3 Queries That Pharmaceutical Sector Seeks In 2023
2023 can be challenging for the pharmaceutical sector as it will mark the rollout of certain important drug pricing reforms across the US which were put in motion by the last year’s inflation reduction act passage. Not to be...
Drug Research
A Biosimilars Pilot Program Is In The Offering By The FDA
The FDA has gone on to release the Biosimilar User Fee Amendments III Regulatory Science Pilot Program, called the Research Roadmap, to give out more information on the biosimilar regulatory science research pilot program. The agency has gone on...
News
Mesothelioma and the Medical Community: Advances in Treatment and Research
Mesothelioma is a rare and aggressive form of cancer that affects the lining of the lungs, abdomen, and heart. Despite being relatively unknown to the general public, it has a significant impact on the medical community. This is due...
Drug Research
Making Immunotherapy Work In The Tumour Microenvironment
One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer puts forth the cause that tumour cells are resistant to immunotherapy, resulting in new strategies for treatment.
The study, which is led by Johns Hopkins...
Drug Research
UK All Set For New Drug Manufacturing Regulatory Framework
As UK will introduce a customised framework for the innovative medicines’ regulation manufactured at the point where the care is received by the patient, it will be the first country to do so, as per the Medicine and Healthcare...
Clinical Trials
Study Suggests Monoclonal Antibodies Good To Fight Malaria
Only one dose of the monoclonal antibody (mAb) CIS43LS gave out high levels of protection against Malaria in challenge study as per new research.
While the previous research that were conducted put out the fact that the monoclonal antibodies...
Drug Research
There Is More To VEXAS Syndrome Than Previously Perceived
As per a recent study that was published in JAMA, a not so well-known syndrome with high mortality has a much higher prevalence than it was thought. The syndrome called VEXAS was first identified in 2020 in patients who...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.